BNG
Bionano Genomics, Inc.
Stock
Stock
ISIN: US09075F4046
Ticker: BNGO
US09075F4046
BNGO
Price
Price
CHART BY
Frequently asked questions
What is Bionano Genomics, Inc.'s market capitalization?
The market capitalization of Bionano Genomics, Inc. is $11.07M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Bionano Genomics, Inc.?
Bionano Genomics, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$57.26. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Bionano Genomics, Inc.'s stock?
Currently, 4 analysts cover Bionano Genomics, Inc.'s stock, with a consensus target price of $7.333. Analyst ratings provide insights into the stock's expected performance.
What is Bionano Genomics, Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, Bionano Genomics, Inc. reported a revenue of $28.46M.
What is the EBITDA for Bionano Genomics, Inc.?
Bionano Genomics, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$54.00M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Bionano Genomics, Inc.?
Bionano Genomics, Inc. has a free cash flow of -$45.38M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Bionano Genomics, Inc. have, and what sector and industry does it belong to?
Bionano Genomics, Inc. employs approximately 100 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Bionano Genomics, Inc.'s shares?
The free float of Bionano Genomics, Inc. is 3.35M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $11.07M
- EPS (TTM)
- -$57.26
- Free Float
- 3.35M
- Revenue (TTM)
- $28.46M
- EBITDA (TTM)
- -$54.00M
- Free Cashflow (TTM)
- -$45.38M
Pricing
- 52W span
- $2.69$42.10
Analyst Ratings
The price target is $7.333 and the stock is covered by 4 analysts.
Buy
2
Hold
2
Sell
0
Information
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
- Employees
- 100
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US09075F4046
- Primary Ticker
- BNGO
Fundamentals & EOD data from FactSet